Default company panoramic image
Logo

Immunoclin

ImmunoClin Limited (“ImmunoClin”), a 10 year old privately owned, self-funded healthcare company (clinical immunology) headed by Dr Dorothy Bray, ex GSK Dire...

  • Stage Product In Development
  • Industry Biotechnology
  • Location Paris, IDF, France
  • Currency EUR

Company Summary

ImmunoClin Limited (“ImmunoClin”), a 10 year old privately owned, self-funded healthcare company (clinical immunology) headed by Dr Dorothy Bray, ex GSK Director, is looking for funding to develop its lead product and pipeline portfolio of innovative R&D products. ImmunoClin’s lead product, Primaleukin™ is a broad-spectrum anti-infective agent initially indicated for first-line, urgent treatment of acute, life-threatening infections in a hospital

Team

  • Default avatar
    Dorothy Bray
    Dr

    • extensive experience in drug development while serving in various senior positions at GlaxoSmithKline and its predecessors
    • led industry-driven international program of several hundred international studies, including over a hundred conducted in developing countries
    • involved in multiple international research programs funded by the UK Medical Research Council, Rockefeller Foundation and the U.S. National Institutes of Health
    • advised on

  • Default avatar
    Kadija Benlhassan Chahour
    Dr

    • joined ImmunoClin in 2006, responsible for lab operations in Paris
    • 10 year experience in immunology research
    • worked for French nuclear agency (CEA) in France on a multicentre project in collaboration with INSERM and Pasteur Institute and then for Biopharm Centre of Excellence in Drug Discovery at GlaxoSmithKline R&D, UK
    • was a project manager in Health Benefits & Immunology, responsible for design and conduct of clinical trials, for DA